HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.

Abstract
Phorbol esters such as phorbol 12-myristate 13-acetate (PMA) have been reported to modulate diverse cellular responses through signal transduction pathways including the protein kinase C (PKC) pathway. In the present study, we sought to determine the effect of PMA on mucin gene expression and on the biological properties of a human colon cancer cell line, HM3. The cells were treated for 8 and 24 h with various concentrations of PMA and total RNA was extracted and Northern and slot blot analyses were carried out using MUC2, MUC3 and MUC5AC mucin cDNA probes to assess the steady state levels of mRNA. Spent media were collected and the level of cancer associated carbohydrate antigens (T, Tn, sialyl Tn, sialyl Lex, and sialyl Lea) and matrix-degrading metalloproteinase (MMPs) activity were examined. Trypsinized cells were used for assessing in vitro invasion, motility and adhesion to matrigel. Our results showed that PMA caused upregulation of steady state mRNA levels of MUC2, MUC3 and MUC5AC which was inhibited after treatment with protein synthesis inhibitors. Calphostin C, a highly specific inhibitor of protein kinase C significantly inhibited the PMA induced induction of mRNA levels of MUC2, MUC3, and MUC5AC. The levels of all cancer-associated mucin carbohydrate antigens examined in the media were increased by PMA treatment. PMA also caused an increase in MMPs activity and in in vitro invasion and motility properties, but did not affect adhesion of HM3 cells to matrigel. Thus, PMA caused a significant increase in the expression of all three mucin genes through signaling pathways involving protein kinase C and increased secretion of mucin associated carbohydrate antigens. These changes were associated with increases in MMP activity as well as by increases in the invasive and motility properties of HM3 colon cancer cells. These data suggest that protein kinase C signaling pathways may be involved in mucin gene regulation and in modulating the invasive and metastatic properties of colon cancer cells.
AuthorsS Y Han, M S Lee, H R Kim, S H Baek, D H Ahn, H S Chae, R H Erickson, M H Sleisenger, Y S Kim
JournalInternational journal of oncology (Int J Oncol) Vol. 17 Issue 3 Pg. 487-94 (Sep 2000) ISSN: 1019-6439 [Print] Greece
PMID10938388 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Neoplasm
  • Carcinogens
  • Drug Combinations
  • Enzyme Inhibitors
  • Laminin
  • MUC2 protein, human
  • MUC5AC protein, human
  • Mucin 5AC
  • Mucin-2
  • Mucin-3
  • Mucins
  • Naphthalenes
  • Neoplasm Proteins
  • Proteoglycans
  • RNA, Messenger
  • RNA, Neoplasm
  • matrigel
  • Collagen
  • Protein Kinase C
  • Metalloendopeptidases
  • calphostin C
  • Tetradecanoylphorbol Acetate
Topics
  • Adenocarcinoma (genetics, metabolism, pathology)
  • Antigens, Neoplasm (biosynthesis, genetics)
  • Carcinogens (pharmacology)
  • Cell Adhesion (drug effects)
  • Cell Movement (drug effects)
  • Collagen
  • Colonic Neoplasms (genetics, metabolism, pathology)
  • Drug Combinations
  • Enzyme Induction (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Laminin
  • Metalloendopeptidases (biosynthesis, genetics)
  • Mucin 5AC
  • Mucin-2
  • Mucin-3
  • Mucins (biosynthesis, genetics)
  • Naphthalenes (pharmacology)
  • Neoplasm Invasiveness
  • Neoplasm Proteins (biosynthesis, genetics)
  • Protein Kinase C (antagonists & inhibitors, metabolism)
  • Proteoglycans
  • RNA, Messenger (biosynthesis, genetics)
  • RNA, Neoplasm (biosynthesis, genetics)
  • Signal Transduction (drug effects)
  • Tetradecanoylphorbol Acetate (pharmacology)
  • Tumor Cells, Cultured (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: